Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02658032 · ClinicalTrials.gov registry record · NA
Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer (PIP)
A NA study of Smoking Cessation and Biofeedback, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 276
- Enrollment target
- 2
- Study locations
NCT02658032 is a NA study of Smoking Cessation and Biofeedback that has completed, run by Yale University. The registered enrollment target is 276 participants, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (42% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT02658032, a NA study of Smoking Cessation and Biofeedback, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 276 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to test the efficacy of two separate, sequential interventions to promote tobacco cessation/reduction in patients who are screened for lung cancer or are eligible for lung cancer screening. Each intervention will be compared to standard of care. The first intervention will be a personalized message intervention, the second intervention will consist of a biofeedback-based intervention.
Conditions Studied
Interventions
- OTHER standard care
- BEHAVIORAL personalized cessation care
- BEHAVIORAL bio feedback
Study Locations (2)
Connecticut
- Yale University - New Haven
South Carolina
- Medical University of South Carolina: Hollings Cancer Center - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2016-01 |
| Est. Completion | 2020-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02658032
The ClinicalTrials.gov registry entry for NCT02658032 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 276 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (42% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 3 interventions - of which standard care is the first listed.
NCT02658032 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, South Carolina.
Frequently Asked Questions
What is clinical trial NCT02658032 about?
NCT02658032 is a clinical study titled "Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer (PIP)". The purpose of this study is to test the efficacy of two separate, sequential interventions to promote tobacco cessation/reduction in patients who are screened for lung cancer or are eligible for lung cancer screening. Each intervention will be compared to standard of care. The first intervention wi...
What is the current status of trial NCT02658032?
This trial is currently completed. It is a NA study. The enrollment target is 276 participants. The study started on 2016-01. Estimated completion is 2020-10.
What conditions does trial NCT02658032 study?
This clinical trial studies the following conditions: Smoking Cessation, Biofeedback.
What interventions are being tested in trial NCT02658032?
The interventions under investigation include: standard care (OTHER), personalized cessation care (BEHAVIORAL), bio feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT02658032?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02658032 being conducted?
This trial has 2 study locations across Connecticut, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.